What Happened?
Eden Prairie, MN-based Miromatrix Medical Appointed Robert Cohen as Chief Executive Officer
About the Company
The Miromatrix Medical technology has the potential to enable the creation of fully biological replacement organs for the human body. In addition to the Company’s internal efforts focused on the development of its first product – a biological mesh for hernia repair – scientists around the globe are working with the Company’s technology and are taking critical steps toward the creation of human organs including the liver, lung, kidney, pancreas and heart. While our biological mesh development program has been conducted internally, our intent is for current and future products to be developed both at Miromatrix and in partnership with the best among those external groups already working with our technology in order to utilize this pre-existing expertise to develop individual products in the most efficacious, cost-effective and timely way possible.
About the Person
Mr. Robert Cohen serves as Chief Executive Officer and President of Miromatrix Medical Inc. Mr. Cohen served as Chief Executive Officer and President of Travanti Pharma, Inc. since January 1, 2005 and September 1, 2004 respectively. Mr. Cohen served as Chief Executive Officer of Advanced Circulatory Systems, Inc. from 2003 to 2004. He served as Vice President of Business and Technology Development at St. Jude Medical, Inc. from 1998 to 2002. During 1992, he served as President and Chief Executive Officer of GCI Medical, Inc. From 1981 to 1992, he served for Pfizer Inc., a global pharmaceutical, medical device and consumer products company, in many capacities, culminating in his appointment as Vice President, Business Development at a division of the Pfizer Hospital Products Group. Prior to St. Jude Medical, Inc., he served as Group Vice President Sulzer Medica from 1992 to 1998. He served as Director of Travanti Pharma, Inc. since September 1, 2004. Mr. Cohen has served on the Boards of several early-stage medical device companies, including Horizon Medical Products and Cardio Focus, Inc. He served as Director of Advanced Circulatory Systems, Inc. from 2003 to 2004. He received a BA from Bates College and a JD from the University of Maine.
Info Source
News
Short Profile